Total Payments
$11,461
2024 Payments
$111.83
Companies
41
Transactions
442
Medicare Patients
1,315
Medicare Billing
$365,631
Payment Breakdown by Category
Food & Beverage$11,117 (97.0%)
Education$343.61 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,117 | 424 | 97.0% |
| Education | $343.61 | 18 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,277 | 44 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,014 | 41 | $0 (2023) |
| Amgen Inc. | $891.33 | 31 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $818.76 | 25 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $703.55 | 25 | $0 (2023) |
| Vifor Pharma, Inc. | $566.19 | 26 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $527.35 | 31 | $0 (2024) |
| Relypsa, Inc. | $505.58 | 35 | $0 (2020) |
| AKEBIA THERAPEUTICS INC | $461.52 | 18 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $397.24 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $111.83 | 6 | OPKO Pharmaceuticals, LLC ($82.09) |
| 2023 | $801.63 | 40 | AstraZeneca Pharmaceuticals LP ($175.57) |
| 2022 | $1,393 | 64 | Bayer HealthCare Pharmaceuticals Inc. ($255.77) |
| 2021 | $1,987 | 59 | AstraZeneca Pharmaceuticals LP ($436.96) |
| 2020 | $900.74 | 49 | AstraZeneca Pharmaceuticals LP ($189.15) |
| 2019 | $2,248 | 74 | Amgen Inc. ($311.69) |
| 2018 | $2,325 | 79 | Mallinckrodt LLC ($421.79) |
| 2017 | $1,694 | 71 | Mallinckrodt LLC ($375.21) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.53 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.91 | General |
| Category: NEPHROLOGY | ||||||
| 03/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.12 | General |
| Category: NEPHROLOGY | ||||||
| 01/19/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEPHROLOGY | ||||||
| 01/08/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.53 | General |
| Category: NEPHROLOGY | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.53 | General |
| Category: NEPHROLOGY | ||||||
| 10/18/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: NEPHROLOGY | ||||||
| 09/20/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Rare Disease | ||||||
| 09/08/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.55 | General |
| Category: NEPHROLOGY | ||||||
| 08/24/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/21/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Nephrology | ||||||
| 08/20/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Hyperkalemia | ||||||
| 08/10/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Hyperkalemia | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEPHROLOGY | ||||||
| 07/17/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $26.02 | General |
| Category: NEPHROLOGY | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 06/23/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 06/21/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEPHROLOGY | ||||||
| 06/20/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $25.30 | General |
| 06/12/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 188 | 255 | $115,076 | $40,415 |
| 2022 | 10 | 357 | 623 | $217,145 | $101,795 |
| 2021 | 10 | 350 | 717 | $230,780 | $122,298 |
| 2020 | 10 | 420 | 792 | $229,690 | $101,123 |
Total Patients
1,315
Total Services
2,387
Medicare Billing
$365,631
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 60 | 99 | $69,894 | $27,150 | 38.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 23 | 29 | $17,052 | $6,090 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 66 | $17,028 | $3,631 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 61 | $11,102 | $3,543 | 31.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 32 | 164 | $82,000 | $46,975 | 57.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 48 | 72 | $53,496 | $20,814 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 137 | $19,660 | $7,974 | 40.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2022 | 17 | 28 | $11,200 | $6,941 | 62.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 63 | $12,651 | $5,625 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 54 | $8,028 | $3,030 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $6,545 | $2,985 | 45.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 34 | $6,920 | $2,854 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,745 | $1,930 | 51.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 14 | $2,800 | $1,341 | 47.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 15 | 23 | $10,100 | $1,326 | 13.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 33 | 274 | $137,000 | $81,686 | 59.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 113 | $20,905 | $10,401 | 49.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 127 | $15,950 | $8,069 | 50.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2021 | 18 | 22 | $8,800 | $5,527 | 62.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $6,200 | $3,900 | 62.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 39 | $7,800 | $3,367 | 43.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 23 | $4,600 | $2,616 | 56.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 26 | 42 | $21,000 | $2,572 | 12.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 13 | $3,575 | $2,177 | 60.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 33 | $4,950 | $1,983 | 40.1% |
About Dr. Jeffrey Clement, MD
Dr. Jeffrey Clement, MD is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164420576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Clement, MD has received a total of $11,461 in payments from pharmaceutical and medical device companies, with $111.83 received in 2024. These payments were reported across 442 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,117).
As a Medicare-enrolled provider, Clement has provided services to 1,315 Medicare beneficiaries, totaling 2,387 services with total Medicare billing of $365,631. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Providence, RI
- Active Since 07/09/2005
- Last Updated 12/04/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164420576
Products in Payments
- Veltassa (Drug) $1,072
- ACTHAR (Biological) $874.18
- JYNARQUE (Drug) $791.76
- LOKELMA (Drug) $699.26
- Auryxia (Drug) $526.97
- Velphoro (Drug) $492.11
- FARXIGA (Drug) $477.81
- Parsabiv (Biological) $436.71
- Kerendia (Drug) $397.24
- RAYALDEE (Drug) $387.52
- Parsabiv (Drug) $365.71
- KRYSTEXXA (Biological) $353.94
- NORTHERA (Drug) $278.18
- AURYXIA (Drug) $269.76
- BENLYSTA (Biological) $269.05
- SAMSCA (Drug) $263.37
- LUPKYNIS (Drug) $244.73
- JARDIANCE (Drug) $226.12
- XARELTO (Drug) $214.26
- INJECTAFER (Drug) $210.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Internal Medicine $154,470
Farah Moustafa, Md, MD
Internal Medicine — Payments: $50,984
Internal Medicine $50,984
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Internal Medicine $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Internal Medicine $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Internal Medicine $36,352
Dr. Peter Barth, M.d, M.D
Internal Medicine — Payments: $29,192
Internal Medicine $29,192